Literature DB >> 7124987

Interaction between antidepressants and perphenazine in psychiatric inpatients.

M Linnoila, L George, S Guthrie.   

Abstract

In a study of 99 patients receiving amitriptyline or nortriptyline alone and 60 patients receiving one of these antidepressants in combination with perphenazine, the patients receiving the combination medication had up to 70% higher antidepressant plasma levels than patients receiving the antidepressant alone. The groups did not differ significantly in sex, age, smoking behavior, or antidepressant dose level. Due to the possibility of side effects from such combination medication, the authors recommend that depressed patients not responding to the tertiary amine tricyclic antidepressants receive a trial of high doses of the drugs before antidepressant-neuroleptic combinations are administered.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7124987     DOI: 10.1176/ajp.139.10.1329

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  7 in total

1.  [Fatal poisoning by protriptyline and haloperidol following an extreme overdose].

Authors:  G Fechner; I Magureanu; R Aderjan; G Schmidt
Journal:  Z Rechtsmed       Date:  1986

Review 2.  Perphenazine for schizophrenia.

Authors:  Benno Hartung; Stephanie Sampson; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2015-03-06

Review 3.  Clinically significant drug interactions with antidepressants in the elderly.

Authors:  Edoardo Spina; Maria Gabriella Scordo
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

4.  Combined thioridazine and desipramine: early antidepressant response.

Authors:  J A Bennett; J Hirschowitz; F Zemlan; D N Thurman; D L Garver
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  The effects of beta-adrenoceptor antagonists and levomepromazine on the metabolic ratio of debrisoquine.

Authors:  J Kallio; R Huupponen; M Seppälä; E Säkö; E Iisalo
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

6.  Inhibitory effects of neuroleptics on debrisoquine oxidation in man.

Authors:  E K Syvälahti; R Lindberg; J Kallio; M De Vocht
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

Review 7.  Augmentation with antidepressants in schizophrenia treatment: benefit or risk.

Authors:  Ye-Meng Mao; Ming-Dao Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-16       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.